Most clinicians feel DES exposure does not contraindicate OC use.
D001695:Biology; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003625:Data Collection; D003695:Delivery of Health Care; D004054:Diethylstilbestrol; D004194:Disease; D004703:Endocrine System; D004967:Estrogens; D005193:Family Planning Services; D006262:Health; D006282:Health Personnel; D006728:Hormones; D009369:Neoplasms; D010820:Physicians; D010827:Physiology; D012102:Reproductive Control Agents; D012106:Research; D012494:Sampling Studies; D002583:Uterine Cervical Neoplasms; D014625:Vaginal Neoplasms
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D004967:Estrogens; D006728:Hormones; D012102:Reproductive Control Agents; D004054:Diethylstilbestrol
Biology; Cancer; Cervical Cancer--etiology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Methods--contraindications; Delivery Of Health Care; Diethylstilbestrol--side effects; Diseases; Endocrine System; Estrogens; Family Planning; Health; Health Personnel; Hormones; Neoplasms; Oral Contraceptives; Oral Contraceptives, Combined--contraindications; Physicians; Physiology; Reproductive Control Agents; Research Methodology; Sampling Studies; Studies; Surveys; Vaginal Cancer--etiology